文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

美国常规免疫疫苗安全性:更新版系统综述与荟萃分析

Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis.
PubMed 文献 · Vaccine · 2021-05-25

结果显示疫苗与严重关键不良事件关联极少,但罕见事件研究仍具挑战,接种获益需与不良事件风险权衡。

要点

  • MMR疫苗与自闭症风险增加无关(高证据强度),但发热性惊厥风险增加(高证据强度)。
  • 轮状病毒疫苗最新随访未显示肠套叠风险增加(中等证据强度),糖尿病风险亦无增加(高证据强度)。
  • 孕妇接种Tdap疫苗未显示关键不良事件风险增加,包括死产(中等证据强度)。

核心结论

  • 在大规模研究中,疫苗与严重关键不良事件的关联极少,但罕见事件难以研究,不良事件应与疫苗保护获益权衡。

研究设计与样本

  • 共审查56,603条引文,最终纳入338项研究(518篇出版物),遵循循证实践中心方法学评估证据强度(SoE),并在PROSPERO注册(CRD42020180089)。

主要发现

  • 儿童:MMR疫苗与自闭症风险增加无关(高SoE),与发热性惊厥风险增加相关(高SoE)。
  • 儿童:轮状病毒疫苗最新随访未显示肠套叠风险增加(中等SoE),糖尿病风险无增加(高SoE)。
  • 儿童:九价人乳头瘤病毒疫苗和B群脑膜炎球菌疫苗等新疫苗,关键不良事件无风险增加证据或证据不足。
  • 成人:新型佐剂灭活流感疫苗和重组佐剂带状疱疹疫苗,关键不良事件无风险增加证据(SoE不一)或证据不足。
  • 孕妇:接种破伤风、白喉和无细胞百日咳(Tdap)疫苗后关键不良事件无风险增加证据(SoE不一),包括死产(中等SoE)。

临床怎么用

  • 预防医学与公共卫生医生可依据本综述向公众传达:MMR疫苗不增加自闭症风险,但需告知发热性惊厥风险增加。
  • 对于轮状病毒疫苗、Tdap疫苗等,可说明现有证据未显示关键不良事件风险增加,但需持续监测罕见事件。

局限性

  • 罕见不良事件难以通过现有研究充分评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Understanding the safety of vaccines is critical to inform decisions about vaccination. Our objective was to conduct a systematic review of the safety of vaccines recommended for children, adults, and pregnant women in the United States. METHODS: We searched the literature in November 2020 to update a 2014 Agency for Healthcare Research and Quality review by integrating newly available data. Studies of vaccines that used a comparator and reported the presence or absence of key adverse events were eligible. Adhering to Evidence-based Practice Center methodology, we assessed the strength of evidence (SoE) for all evidence statements. The systematic review is registered in PROSPERO (CRD42020180089). RESULTS: Of 56,603 reviewed citations, 338 studies reported in 518 publications met inclusion criteria. For children, SoE was high for no increased risk of autism following measles, mumps, and rubella (MMR) vaccine. SoE was high for increased risk of febrile seizures with MMR. There was no evidence of increased risk of intussusception with rotavirus vaccine at the latest follow-up (moderate SoE), nor of diabetes (high SoE). There was no evidence of increased risk or insufficient evidence for key adverse events for newer vaccines such as 9-valent human papillomavirus and meningococcal B vaccines. For adults, there was no evidence of increased risk (varied SoE) or insufficient evidence for key adverse events for the new adjuvanted inactivated influenza vaccine and recombinant adjuvanted zoster vaccine. We found no evidence of increased risk (varied SoE) for key adverse events among pregnant women following tetanus, diphtheria, and acellular pertussis vaccine, including stillbirth (moderate SoE). CONCLUSIONS: Across a large body of research we found few associations of vaccines and serious key adverse events; however, rare events are challenging to study. Any adverse events should be weighed against the protective benefits that vaccines provide.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gidengil C, Goetz MB, Newberry S, et al. Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis. Vaccine. 2021. PMID: 34049735. doi:10.1016/j.vaccine.2021.03.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。